Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Top Cited Papers
- 16 May 2013
- journal article
- review article
- Published by Elsevier BV in Cell Metabolism
- Vol. 17 (6), 819-837
- https://doi.org/10.1016/j.cmet.2013.04.008
Abstract
No abstract availableKeywords
Funding Information
- Canada Research Chairs
- Canadian Institutes of Health Research (MOP 82700)
This publication has 148 references indexed in Scilit:
- A local glucagon-like peptide 1 (GLP-1) system in human pancreatic isletsDiabetologia, 2012
- Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null miceDiabetologia, 2012
- Nutrient detection by incretin hormone secreting cellsPhysiology & Behavior, 2012
- Chylomicron Formation and Secretion is Required for Lipid‐Stimulated Release of Incretins GLP‐1 and GIPLipids, 2012
- Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasisDiabetologia, 2011
- Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Provides Neuroprotection in Mice Transient Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 2011
- Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challengeNature Genetics, 2010
- Differential Importance of Glucose-Dependent Insulinotropic Polypeptide vs Glucagon-Like Peptide 1 Receptor Signaling for Beta Cell Survival in MiceGastroenterology, 2009
- Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphismsDiabetologia, 2007
- Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetesNature Genetics, 2006